Mesa Labs Reports $249.1M FY26 Revenue, SDC Division Surges 17.7% in Q4
MLAB sits 64% above its 52-week low of $55.45 on elevated volume (2.6× avg).
Summary
Mesa Laboratories reported fiscal year 2026 revenue of $249.1 million. The company's SDC division showed strong organic growth, increasing 17.7% in Q4 and 8.7% for the full year. Other divisions presented a mixed picture, with BPD experiencing a significant 29.9% decline in Q4. This detailed financial report follows the company's general announcement yesterday of strong fourth quarter and fiscal year results, providing specific metrics for investors to assess segment performance and overall financial health.
At the time of this announcement, MLAB was trading at $90.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $501.7M. The 52-week trading range was $55.45 to $115.35. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.